ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 713201 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 713201; 2) Community: the network communities that were significantly associated with the response to NSC 713201; 3) Molecule: the relationships between components within communities and NSC 713201; 4) MDR: the compounds that were significantly associated with the NSC 713201.

NSC Compound Enrichment Correlation
NSC 668296 Null 0.0179905510964915 0.23968247
NSC 686362 Null 0.0179905510964915 0.16939827
NSC 700583 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0179905510964915 0.30441529
NSC 705534 Faradiol 0.0179905510964915 0.013172783
NSC 711661 Null 0.0179905510964915 0.33712164
NSC 718781 Erlotinib hydrochloride 0.0186186224062458 -0.22536142
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0186186224062458 0.37090088
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0186186224062458 0.15659913
NSC 753661 methyl ester prodigiosene 0.0186186224062458 0.32199535
NSC 755442 Null 0.0186186224062458 0.19650191
Total:92  Current:45    [First] [Prev] [Next] [Last]